Mon, July 24, 2017
Fri, July 21, 2017
Thu, July 20, 2017
Wed, July 19, 2017
Tue, July 18, 2017

Matthew Harrison Maintained (SRPT) at Hold with Increased Target to $33 on, Jul 20th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-33-on-jul-20th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Increased Target from $31 to $33 on, Jul 20th, 2017.

Matthew has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Mike Guo of "SunTrust Robinson Humphrey" Upgraded from Hold to Strong Buy on, Wednesday, April 5th, 2017